Recursion Pharmaceuticals competitorsClear all

Recursion Pharmaceuticals's top competitors include BenevolentAI, Sarepta Therapeutics, Intellia Therapeutics and CRISPR Therapeutics.

Save Comparison	Recursion Pharmaceuticals Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.	BenevolentAI BenevolentAI is a company engaged in the development and application of artificial intelligence for drug discovery and development.	Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.	Intellia Therapeutics Intellia is developing therapeutic products to help people with genetic diseases.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date	Founding Date 2013	Founding Date 2013	Founding Date 1980	Founding Date 2014	Founding Date 2013
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare artificial intelligence biotech drug development genetics pharma	Tags Technology artificial intelligence drug development medtech pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Salt Lake City, US HQ	Locations London, GB HQ Babraham, GB Brooklyn, US	Locations Cambridge, US HQ Boulogne Billancourt, FR Berlin, DE Dublin, IE Milano, IT Chiyoda City, JP see more	Locations Cambridge, US HQ	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US
Employees	Employees 1913% increase	Employees 2761% decrease	Employees 74349% increase	Employees 27028% increase	Employees 30462% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 1 b	Valuation ($) 7.6 b	Valuation ($) 4.8 b	Valuation ($) 14.2 b
Twitter followers	Twitter followers 3.8 k	Twitter followers 6.5 k	Twitter followers 3 k	Twitter followers 5.8 k	Twitter followers 10.9 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 2	Number of tweets (last 30 days) 36	Number of tweets (last 30 days) 16	Number of tweets (last 30 days) 12	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 22.5	Average likes per tweet (last 30 days) 3.6	Average likes per tweet (last 30 days) 15.8	Average likes per tweet (last 30 days) 12.4	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 94.44%	Percentage of tweets with engagement (last 30 days) 93.75%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 292115	Alexa Website Rank 280386	Alexa Website Rank 315290	Alexa Website Rank 264531	Alexa Website Rank 190330
Employee Rating	Employee Rating 4.7	Employee Rating 3.8	Employee Rating 3.6	Employee Rating 3.7	Employee Rating 3.3
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £6.8m (FY, 2018)	Revenue (est.) $380.8m (FY, 2019)	Revenue (est.) $43.1m (FY, 2019)	Revenue (est.) $289.6m (FY, 2019)
Gross profit	Gross profit N/A	Gross profit £6.8m (FY, 2018)	Gross profit N/A	Gross profit $43.1m (FY, 2019)	Gross profit N/A
Net income	Net income N/A	Net income (£26.9m) (FY, 2018)	Net income ($715.1m) (FY, 2019)	Net income ($99.5m) (FY, 2019)	Net income $66.9m (FY, 2019)
Funding
Latest funding round	Latest funding round $ 239m (5 months ago)	Latest funding round $ 90m (over 1 year ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 437.1m	Total funding raised $ 305m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 127m